Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease

[1]  A. Rowlerson,et al.  Isolation and quantitative immunocytochemical characterization of primary myogenic cells and fibroblasts from human skeletal muscle. , 2015, Journal of visualized experiments : JoVE.

[2]  I. Pipinos,et al.  Abnormal Accumulation of Desmin in Gastrocnemius Myofibers of Patients with Peripheral Artery Disease , 2015, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[3]  I. Pipinos,et al.  Oxidative damage in the gastrocnemius of patients with peripheral artery disease is myofiber type selective , 2014, Redox biology.

[4]  H. Horita,et al.  Vascular Smooth Muscle Cell–Derived Transforming Growth Factor-&bgr; Promotes Maturation of Activated, Neointima Lesion–Like Macrophages , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[5]  N. Frangogiannis,et al.  The pathogenesis of cardiac fibrosis , 2014, Cellular and Molecular Life Sciences.

[6]  I. Pipinos,et al.  Oxidative damage and myofiber degeneration in the gastrocnemius of patients with peripheral arterial disease , 2013, Journal of Translational Medicine.

[7]  Xiong-qing Huang,et al.  Vascular fibrosis in atherosclerosis. , 2013, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[8]  I. Pipinos,et al.  Human Enterovirus in the Gastrocnemius of Patients With Peripheral Arterial Disease , 2013, Journal of the American Heart Association.

[9]  A. Samal,et al.  Morphometric analysis of gastrocnemius muscle biopsies from patients with peripheral arterial disease: objective grading of muscle degeneration. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.

[10]  I. Pipinos,et al.  Quantification of Cytokines in the Gastrocnemius and Serum of Claudicating Patients With Peripheral Arterial Disease , 2013 .

[11]  H. Shimokawa,et al.  Coronary perivascular fibrosis is associated with impairment of coronary blood flow in patients with non-ischemic heart failure. , 2012, Journal of cardiology.

[12]  G. Owens,et al.  Smooth muscle cell phenotypic switching in atherosclerosis. , 2012, Cardiovascular research.

[13]  T. Wynn,et al.  Mechanisms of fibrosis: therapeutic translation for fibrotic disease , 2012, Nature Medicine.

[14]  L. Ferrucci,et al.  Calf muscle characteristics, strength measures, and mortality in peripheral arterial disease: a longitudinal study. , 2012, Journal of the American College of Cardiology.

[15]  S. Santilli,et al.  Hypoxia differentially regulates arterial and venous smooth muscle cell proliferation via PDGFR-β and VEGFR-2 expression. , 2012, American journal of physiology. Heart and circulatory physiology.

[16]  N. Frangogiannis,et al.  Transforming growth factor (TGF)-β signaling in cardiac remodeling. , 2011, Journal of molecular and cellular cardiology.

[17]  N. Frangogiannis,et al.  TGF-β signaling in fibrosis , 2011, Growth factors.

[18]  C. Mann,et al.  Aberrant repair and fibrosis development in skeletal muscle , 2011, Skeletal Muscle.

[19]  S. Fisher.  Vascular smooth muscle phenotypic diversity and function. , 2010, Physiological genomics.

[20]  N. Stergiou,et al.  Abnormal joint powers before and after the onset of claudication symptoms. , 2010, Journal of vascular surgery.

[21]  C. Stefanski,et al.  Excessive collagen accumulation in dystrophic (mdx) respiratory musculature is independent of enhanced activation of the NF-κB pathway , 2010, Journal of the Neurological Sciences.

[22]  J. Olin,et al.  Peripheral artery disease: current insight into the disease and its diagnosis and management. , 2010, Mayo Clinic proceedings.

[23]  S. Lele,et al.  Udp‐glucose dehydrogenase as a novel field‐specific candidate biomarker of prostate cancer , 2010, International journal of cancer.

[24]  S. Lele,et al.  Tissue-based quantification of 8-hydroxy-2'-deoxyguanosine in human prostate biopsies using quantitative fluorescence imaging analysis. , 2009, Urology.

[25]  R. Gomer,et al.  Identification of Markers that Distinguish Monocyte-Derived Fibrocytes from Monocytes, Macrophages, and Fibroblasts , 2009, PloS one.

[26]  L. Ferrucci,et al.  Pathophysiological Changes in Calf Muscle Predict Mobility Loss at 2-Year Follow-Up in Men and Women With Peripheral Arterial Disease , 2009, Circulation.

[27]  Ping Wu,et al.  NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-{beta}1 and insulin-like growth factor binding protein-3. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[28]  I. Pipinos,et al.  The Myopathy of Peripheral Arterial Occlusive Disease: Part 1. Functional and Histomorphological Changes and Evidence for Mitochondrial Dysfunction , 2008, Vascular and endovascular surgery.

[29]  Eric Vicaut,et al.  Impaired Tissue Perfusion: A Pathology Common to Hypertension, Obesity, and Diabetes Mellitus , 2008, Circulation.

[30]  I. Pipinos,et al.  Basic Science Review: The Myopathy of Peripheral Arterial Occlusive Disease: Part 2. Oxidative Stress, Neuropathy, and Shift in Muscle Fiber Type , 2008, Vascular and endovascular surgery.

[31]  H. Coller,et al.  An Immunohistochemical Method for Identifying Fibroblasts in Formalin-fixed, Paraffin-embedded Tissue , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[32]  Lynette M. Smith,et al.  Quantitative Fluorescence Imaging Analysis for Cancer Biomarker Discovery: Application to β-Catenin in Archived Prostate Specimens , 2007, Cancer Epidemiology Biomarkers & Prevention.

[33]  F. Verrecchia,et al.  Transforming growth factor-β and fibrosis , 2007 .

[34]  L. Norgren,et al.  Inter-society consensus for the management of peripheral arterial disease. , 2007, International angiology : a journal of the International Union of Angiology.

[35]  Marta Ruiz-Ortega,et al.  TGF-β signaling in vascular fibrosis , 2007 .

[36]  N. Shammas,et al.  Epidemiology, classification, and modifiable risk factors of peripheral arterial disease , 2007, Vascular health and risk management.

[37]  Lynette M. Smith,et al.  Quantitative fluorescence imaging analysis for cancer biomarker discovery: application to beta-catenin in archived prostate specimens. , 2007, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[38]  D. Baker,et al.  Increased angiogenic response but deficient arteriolization and abnormal microvessel ultrastructure in critical leg ischaemia , 2006, The British journal of surgery.

[39]  I. Pipinos,et al.  Mitochondrial defects and oxidative damage in patients with peripheral arterial disease. , 2006, Free radical biology & medicine.

[40]  D. Bull,et al.  Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[41]  I. Baumgartner,et al.  Arteriolization of Capillaries and FGF‐2 Upregulation in Skeletal Muscles of Patients with Chronic Peripheral Arterial Disease , 2005, Microcirculation.

[42]  Elizabeth Selvin,et al.  Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States: Results From the National Health and Nutrition Examination Survey, 1999–2000 , 2004, Circulation.

[43]  A. Gardner,et al.  Lack of functional benefits following infrainguinal bypass in peripheral arterial occlusive disease patients , 2001, Vascular medicine.

[44]  V. Velarde,et al.  Mechanisms by which bradykinin promotes fibrosis in vascular smooth muscle cells: role of TGF-beta and MAPK. , 2000, American journal of physiology. Heart and circulatory physiology.

[45]  M. Sekiguchi,et al.  h-Caldesmon as a specific marker for smooth muscle tumors. Comparison with other smooth muscle markers in bone tumors. , 2000, American journal of clinical pathology.

[46]  W. Hiatt,et al.  Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease , 2000, Vascular medicine.

[47]  J. Regensteiner,et al.  Chronic Changes in Skeletal Muscle Histology and Function in Peripheral Arterial Disease , 1993, Circulation.

[48]  Jean Paul Thiery,et al.  Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[49]  G. Gibbons,et al.  Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. , 1992, The Journal of clinical investigation.

[50]  K. Angquist,et al.  Fibre loss and distribution in skeletal muscle from patients with severe peripheral arterial insufficiency. , 1989, European journal of vascular surgery.

[51]  E. Govoni,et al.  Skeletal muscle and peripheral nerve changes caused by chronic arterial insufficiency--significance and clinical correlations--histological, histochemical and ultrastructural study. , 1984, Clinical neuropathology.

[52]  C. Mann,et al.  Cellular and molecular mechanisms regulating fibrosis in skeletal muscle repair and disease. , 2011, Current topics in developmental biology.

[53]  Marta Ruiz-Ortega,et al.  TGF-beta signaling in vascular fibrosis. , 2007, Cardiovascular research.

[54]  P. Doevendans,et al.  Regulation and characteristics of vascular smooth muscle cell phenotypic diversity , 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[55]  F. Verrecchia,et al.  Transforming growth factor-beta and fibrosis. , 2007, World journal of gastroenterology.

[56]  L. Norgren,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, Journal of vascular surgery.

[57]  D. Bull,et al.  Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. , 2006, American journal of physiology. Lung cellular and molecular physiology.